PURIXAN Trademark

Trademark Overview

On Friday, October 18, 2013, a trademark application was filed for PURIXAN with the United States Patent and Trademark Office. The USPTO has given the PURIXAN trademark a serial number of 86095605. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 13, 2020. This trademark is owned by Nova Bio-Pharma Technologies Limited. The PURIXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions and preparations for the treatment of leukaemia
purixan

General Information

Serial Number86095605
Word MarkPURIXAN
Filing DateFriday, October 18, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 13, 2020
Registration Number4618697
Registration DateTuesday, October 7, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical compositions and preparations for the treatment of leukaemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 25, 2013
Primary Code005
First Use Anywhere DateWednesday, June 25, 2014
First Use In Commerce DateWednesday, June 25, 2014

Trademark Owner History

Party NameNova Bio-Pharma Technologies Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLeicestershire LE184YF
GB
Party NameNova Bio-Pharma Technologies Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeicestershire LE184YF
GB
Party NameNova Bio-Pharma Technologies Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeicestershire LE184YF
GB

Trademark Events

Event DateEvent Description
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2013NEW APPLICATION ENTERED
Friday, October 25, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 3, 2014ASSIGNED TO EXAMINER
Saturday, February 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Thursday, September 4, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, September 21, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 13, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 12, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, August 12, 2014USE AMENDMENT FILED
Wednesday, September 3, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 3, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 3, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 7, 2014REGISTERED-PRINCIPAL REGISTER
Monday, October 7, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 13, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 9, 2024TEAS SECTION 8 & 9 RECEIVED
Friday, November 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 13, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, October 7, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

purixan leukaemia treatment preparations compositions pharmaceutical